What is the recommended management of diabetic ketoacidosis in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diabetic Ketoacidosis in Children

Children with DKA should receive continuous IV insulin infusion at 0.05-0.10 units/kg/hour (without an initial bolus) along with isotonic fluid resuscitation, with careful monitoring to prevent cerebral edema, the leading cause of DKA-related mortality in pediatric patients. 1

Initial Assessment and Severity Classification

DKA severity is categorized by acidosis level 1:

  • Mild DKA: venous pH <7.3, bicarbonate <15 mmol/L
  • Moderate DKA: pH <7.2, bicarbonate <10 mmol/L
  • Severe DKA: pH <7.1, bicarbonate <5 mmol/L

Severe DKA requires intensive monitoring with central venous and intra-arterial pressure monitoring plus frequent blood chemistry determinations. 1

Fluid Management

Initial resuscitation with isotonic saline (0.9% NaCl) is now recommended for all patients in the first 20-30 minutes after presentation. 2 This represents a shift from older fluid-limiting protocols, as new evidence shows early isotonic fluid therapy does not increase cerebral edema risk and may improve outcomes. 2

Fluid Protocol:

  • Initial bolus: 10-20 mL/kg of 0.9% saline over first hour 3
  • Subsequent fluids: Calculate to replace 5-10% dehydration over 36-48 hours 1, 2, 3
  • Maintenance rate: Typically 1.5 times the 24-hour maintenance requirements (approximately 5 mL/kg/hour), not exceeding two times maintenance 1
  • Fluid composition: Use at least 0.45% saline after initial resuscitation 4

Insulin Therapy

Critical principle: Fluid infusion should precede insulin administration by 1-2 hours. 3

Insulin Dosing:

  • Standard dose: 0.05-0.10 units/kg/hour as continuous IV infusion 1
  • No initial bolus: IV bolus insulin is not generally recommended for children with DKA 1
  • Goal: Gradually reduce blood glucose by 50-100 mg/dL per hour 1
  • Dose adjustment: If glucose doesn't fall by 50 mg/dL in the first hour, check hydration status and consider doubling insulin infusion hourly until steady decline achieved 1

Important Caveat:

If plasma glucose reaches 250 mg/dL before ketoacidosis resolves, add dextrose (D5 or D10) to IV fluids and continue insulin infusion to clear ketones. 1 The goal is resolution of ketoacidosis, not just normoglycemia.

Electrolyte Management

Potassium Replacement:

Potassium must be replaced early and sufficiently - this is critical as hypokalaemia occurs in approximately 50% of DKA cases during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality. 1, 3

  • Before starting insulin: Exclude hypokalaemia (K+ <3.3 mEq/L) 1
  • Potassium composition: Use 1/3 potassium phosphate and 2/3 potassium chloride or acetate 1
  • Monitoring: Check potassium hourly or more frequently 1

Bicarbonate:

Bicarbonate administration is contraindicated in pediatric DKA. 3 Studies show no difference in resolution of acidosis or time to discharge, and it may increase cerebral edema risk. 1, 4

Monitoring Requirements

Monitor the following parameters hourly or more frequently 1:

  • Blood glucose
  • Potassium concentration
  • Neurological status (critical for detecting cerebral edema)
  • Vital signs

Every 2-4 hours, obtain 1:

  • Serum electrolytes
  • Venous pH (arterial blood gases generally unnecessary)
  • Anion gap
  • Blood urea nitrogen
  • Creatinine
  • Osmolality

Cerebral Edema Prevention and Management

Cerebral edema is the most common cause of death during DKA in children, with mortality rates of 1-3% overall. 1

Risk Factors for Cerebral Edema:

  • Severity of acidosis at presentation 4
  • Greater hypocapnia (after adjusting for acidosis) 4
  • Higher blood urea nitrogen at presentation 4
  • Treatment with bicarbonate 4

Management if Cerebral Edema Suspected:

Intervene rapidly with mannitol or hypertonic saline infusion. 3 Treatment should occur in centers with experience where neurologic status can be monitored frequently.

Transition to Subcutaneous Insulin

Once DKA resolves (pH >7.3, bicarbonate >15 mmol/L, anion gap normalized), transition to subcutaneous insulin 1:

  • Timing: Administer basal insulin 2-4 hours before stopping IV insulin to prevent rebound ketoacidosis 1
  • Dose calculation: Base on average insulin infused during last 12 hours before transition 1

Special Considerations

Recurrent DKA:

Recurrent DKA is almost always due to insulin omission and requires special attention. 1 These children have higher incidence of:

  • Psychiatric illness, especially depression 1
  • Single-parent homes 1
  • Inadequate insurance 1
  • Eating disorders (in adolescents) 1

Psychological counseling is recommended for all children with recurrent DKA and their families. 1

Prevention Strategies:

  • Public awareness of diabetes signs and symptoms 1
  • Education about ketone monitoring 1
  • 24-hour telephone availability for families 1
  • Recognition that insulin omission due to psychological problems and financial barriers is the most common cause of DKA in established diabetes 1

Common Pitfalls to Avoid

  1. Do not give initial insulin bolus in pediatric DKA - this differs from adult protocols 1
  2. Do not use bicarbonate except in extremely rare circumstances 3
  3. Do not restrict fluids excessively - older protocols limiting early fluid resuscitation have not decreased cerebral edema incidence 2
  4. Do not stop insulin when glucose normalizes - continue until ketoacidosis resolves, adding dextrose to fluids as needed 1
  5. Do not delay potassium replacement - start early to prevent life-threatening hypokalaemia 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The management of diabetic ketoacidosis in children.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.